Venture capital deals

November 15, 2013, 9:33 PM UTC
Fortune

GenapSys, a Redwood City, Calif.-based developer of genomic testing systems, has raised $37 million in Series B funding. Yuri Milner and  Stanford StartX Fund were joined by return backers Decheng Capital and IPV Capital. www.genapsys.com

Catabasis Pharmaceuticals Inc., a Cambridge, Mass.-based developer of medicines to treat inflammatory and metabolic diseases, has raised $32.4 million in Series B funding. Lightstone Ventures led the round, and was joined by an unidentified “public crossover fund” and return backers SV Life Sciences, Clarus Ventures, MedImmune Ventures and Advanced Technology Ventures.www.catabasis.com

BrightTag, a Chicago-based marketing technology platform, has raised $27 million in new VC funding led by Yahoo Japan. The company previously raised around $23 million from TomorrowVentures, Pritzker Group Venture Capital, EPIC Ventures, I2A Fund and Baird Venture Partners.www.brighttag.com

Knozen, a stealthy “personality-probing” startup from TheLadders founder Marc Cenedella, has raised $2.25 million in seed funding, according to TechCrunch. Backers include FirstMark Capital, Lerer Ventures, Greycroft Partners and David Tisch. www.knozen.com

Sign up for Dan Primack’s daily email newsletter on deals and deal-makers: GetTermSheet.com